jcmt
Search

Hot Keywords
Biomarker Discovery Autophagy and Cancer Breast Cancer Metastasis Brain Metastases Gastric Cancer Metastasis Lung Cancer Genetic Heterogeneity Colorectal Cancer Prostate Cancer Cancer Immunotherapy Circulating Tumor Cells Neuroendocrine Tumors

Top
  1. Home
  2. About
  3. Editorial Board

Editorial Board

Honorary Editors-in-Chief

  • Dai-Ming Fan
    State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Yan Sun
    Academician of Chinese Society of Engineering, Beijing, China.
    Research Interests: Clinical oncology, non-small cell lung cancer, breast cancer, target therapy

Editor-in-Chief

  • Lucio Miele
    lmiele@lsuhsc.edu
    Department of Genetics, School of Medicine, LSU Health Sciences Center, New Orleans, LA, USA.
    Research Interests: Cancer stem cell-regulatory genes, GWAS, transcriptome, cancer-associated genes, genomic biomarkers

Associate Editors

  • Alessandro Antonelli
    Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
    Research Interests: Thyroid endocrinology, thyroid cancer, new treatment of thyroid cancer
  • Laurence H. Baker
    Departments of Internal Medicine and Pharmacology, University of Michigan, Ann Arbor, MI, USA.
    Research Interests: Sarcoma research, clinical trials, new drug development
    Contributions:
  • Gary L. Clayman
    The Clayman Thyroid Surgery and Thyroid Cancer Center, Tampa, FL, USA.
    Research Interests: Surgical management of thyroid cancer, otolaryngology
  • Pran K. Datta
    School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
    Research Interests: Basic and translational oncology, immunohisyochemlstry, genomics, signaling pathway
  • Ribatti Domenico
    Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy.
    Research Interests: Angiogenesis in hematological tumors, angiogenesis in hematological tumors, angiogenesis in bone tumors, role of mast cells in tumor angiogenesis, role of chemokines in angiogenesis, role of GM-CSF in angiogenesis, role of PDGF and sugars in angiogenesis, role of transferrin in angiogenesis
  • Massimo Federico
    Medical Oncology, CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy.
    Research Interests: Follicular lymphoma, hodgkin lymphoma, T-cell lymphoma
  • Alfio Ferlito
    Coordinator of the International Head and Neck Scientific Group, Padua, Italy.
    Research Interests: Head and neck cancer, clinical practice, teaching and research
  • Umberto Galderisi
    Department of Molecular Biology, Second University of Naples, Naples, Italy.
    Research Interests: Basic and applied researches on normal and cancer stem cells, analysis of senescence processes that affect stem cell properties, effect of low dose radiations on the biology of normal and cancer stem cells
  • Jerome M. Hershman
    Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
    Research Interests: Pathogenesis and management of thyroid cancer
  • Fred R. Hirsch
    Clinical Institute for Lung Cancer, Mount Sinai Cancer, Mount Sinai Health System, Tisch Cancer Institute, Icahn School of Medicine, New York, NY, USA.
    Research Interests: Lung cancer, translational research, targeted therapies, early detection, prognostic markers, personalized lung cancer therapies
  • Ciro Isidoro
    Department of Health Sciences, Università del Piemonte Orientale "A. Avogadro", Novara, Italy.
    Research Interests: Lysosomal proteolysis, pathogenesis of diseases, Cathepsin D, nanobioimaging, autophagy-lysosomal pathway in cancer and in neurodegeneration
  • Gopal C. Kundu
    KIIT Deemed to be University, Institute of Eminence, Bhubaneswar, India.
    Research Interests: Tumor biology, cancer stem cells, tumor-stroma interaction, angiogenesis, cancer therapeutics biomarker development, nanomedicine
  • Yin-Yuan Mo
    Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, USA.
    Research Interests: MicroRNAs and long non-coding RNA in cancers
  • Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Santa Chiara Hospital, Pisa, Italy.
    Research Interests: Breast and gastrointestinal cancer and their metastases, tumour markers, post-operative follow-up, physiopathology, immunology and immunotherapy of cancer, thyroid tumours
  • Godefridus J. Peters
    Laboratory Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
    Research Interests: Pharmacology of anticancer agents, antimetabolites, antifolates, platinum analogs, taxanes, anti-signalling agents, third generation targeted-agents
  • Stephen J. Ralph
    School of Medical Science, Griffith Health Institute, Griffith University, Southport, Queensland, Australia.
    Research Interests: Melanoma vaccines, metastatic cancers, classification of mitocans, effects of laser irradiation on carcinoma
  • Jesus San-Miguel
    Clinica Universitaria de Navarra, Pamplona, Spain.
    Research Interests: Myeloma cell biology, minimal residual disease, proteasome inhibitors, immunomodulatory drugs, histone deacetylases
  • William P. Schiemann
    Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
    Research Interests: TGFβ & cell signaling, breast cancer metastasis & recurrence, metastatic dormancy, breast cancer stem cells, epithelial-mesenchymal transition, tumor heterogeneity, noncoding RNAs, epigenome
  • Hans-Joachim Schmoll
    University Hospital Halle (Saale), Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
    Research Interests: Colorectal cancer, gastrointestinal cancers, genitourinary cancers, germline cancers
  • Gautam Sethi
    Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
    Research Interests: Transcription factors in cancer progression, cell signaling, chemoprevention, pharmaceuticals
  • Fatih M. Uckun
    Vice President, Oncology and Hematology, Worldwide Clinical Trials, Morrisville, NC, USA.
    Research Interests: Developmental therapeutics, biopharmaceuticals, oncology, immuno-oncology, infectious diseases, immunology
  • Jan Baptist Vermorken
    Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.
    Research Interests: Gynecologic oncology, head and neck oncology, breast and colon cancer
  • Masayuki Watanabe
    Department of Gastroenterological Surgery, Esophageal Cancer Division, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
    Research Interests: Esophageal surgery, esophageal squamous cell carcinoma, noncurative endoscopic resection, upfront esophagectomy, minimally invasive surgery
    Contributions:
  • Yaguang Xi
    Department of Genetics, School of Medicine, LSU Health Sciences Center, New Orleans, LA, USA.
    Research Interests: Non-coding RNA, tumor metastasis, cancer chemoprevention, immunotherapy, new drug development

European Editor

  • Klaus Pors
    Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, West Yorkshire, UK.
    Research Interests: Cytochrome, prostate cancer, drug discovery, target oriented synthesis, medicinal chemistry, diversity-oriented synthesis, small molecules, pharmacoepigenetics, molecular fluorescent probes

Editorial Board Members

  • Prasad S. Adusumilli
    Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
    Research Interests: Lung cancer, esophageal cancer, mediastinal and chest wall tumors, mesothelioma, thymoma, metastatic lung cancers, laparoscopy, lobectomy, bronchoscopy, pleurectomy
  • Heike Allgayer
    Medical Faculty Mannheim, Ruprecht Karls University Heidelberg, Mannheim, Germany.
    Research Interests: Tumor progression, invasion and metastasis, molecular determinants of response to novel therapeutics, translational research, molecular staging of cancer
  • Alexandre Arcaro
    Department of Clinical Research, Division of Pediatric Hematology/Oncology, University of Bern, Bern, Switzerland.
    Research Interests: Cancer research, oncology, biochemistry, molecular biology, pharmacology
  • Ahmad Awada
    Department of Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
    Research Interests: Clinical development of new anticancer agents, cytotoxics, molecular-targeted therapies, immunotherapy
  • Rossana Berardi
    Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy.
    Research Interests: Non-small cell lung cancer, PD-1/PD-L1 checkpoint inhibitors, metastatic breast cancer
    Contributions:
  • Dominique Bonnet
    Haematopoietic Stem Cell Laboratory, Francis Crick Institute, London, UK.
    Research Interests: Haematopoietic stem cells, blood cancer
  • Ting-Chang Chang
    Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, China.
    Research Interests: Molecular markers, gynecologic cancer,endometrial cancer Immune therapy, targeted therapy, recurrent/metastatic gynecologic cancer
  • Yang-Chao Chen
    School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin NT, Hong Kong, China.
    Research Interests: Epigenetics in cancer, histone modification particularly methylation, long and short non-coding RNAs, development of novel therapeutics for liver and pancreatic cancer
  • Chun Hei Antonio Cheung, PhD
    Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, China.
    Research Interests: Anti-cancer nanodrug development, cancer drug resistance mechanism, cancer cell autophagy
  • Ssang-Goo Cho
    Department of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul, South Korea.
    Research Interests: Signaling pathways in stem, cancer, and cancer stem cells, molecular mechanism of cellular reprogramming and apoptosis, pancreatic beta-cell, immune-cell, kidney differentiation & organoid culture
  • Judy Crabtree
    Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
    Research Interests: Neuroendocrine and hormone-dependent oncogenesis, cancer stem cells, retinoblastoma binding protein 2
  • Giuseppe Curigliano
    Istituto Europeo di Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico, University of Milano, Milan, Italy.
    Research Interests: Early drug development, solid tumours, breast cancer
    Contributions:
  • Francesca Demichelis, PhD
    Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
    Research Interests: Cancer genomics, prostate cancer, cancer evolution and progression, identification of germline and somatic diagnostic and prognostic cancer biomarkers
  • Marco Falasca
    Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia.
    Research Interests: Signalling pathways, intracellular physiological and pathological processes, lysophospholipid lysophosphatidylinositol, phosphoinositide 3-kinase isoforms and phospholipase Cgamma-1, phosphoinositides, ABC transporters, G-protein coupled receptors, cancer progression and cell signalling
  • Mirco Fanelli
    Department of Biomolecular Sciences, University of Urbino 'Carlo Bo', Molecular Pathology Lab, Fano, Italy.
    Research Interests: Molecular features of gliomas
  • Bingliang Fang
    Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Research Interests: Innovative anticancer agents, targeted cancer therapy, the mechanisms of action of and/or resistance to anticancer agents, molecular signatures or biomarkers for predicting treatment response or early diagnosis of lung cancers
    Contributions:
  • Renty B. Franklin
    Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, MD, USA.
    Research Interests: Prostate cancer and treatment, screening methods for prostate cancer, development and progression of malignancy
  • Minoru Fukuda
    Nagasaki University Clinical Oncology Center, Nagasaki, Japan.
    Research Interests: Cell surface carbohydrates, tumor metastasis, neural cell-specific glycans, mucin-type O-glycans, immune cell interactions, carbohydrate-dependent adhesion, helicobacter pylori-mediated inflammation and cancer
  • Lombardi Giuseppe
    Medical Oncology 1 Unit, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy.
    Research Interests: Brain tumor, glioblastoma
    Contributions:
  • Heiko Hermeking
    Experimental and Molecular Pathology, Pathologisches Institut, Ludwig-Maximilians-Universität München, Germany.
    Research Interests: Analysis of genes, microRNAs and pathways that are regulated by c-MYC or p53
  • Elif Hindié
    CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France.
    Research Interests: Imaging in endocrinology, TEP imaging in oncology, internal vectored radiation therapy, theranostic applications
  • Egidio Iorio
    Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy.
    Research Interests: Leukemic cell proliferation, chemotherapeutic sensitivity, acute myeloid leukemia, molecular and imaging biomarkers, inflammation in oncology
  • Robert Kratzke
    Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
    Research Interests: Translational mesothelioma and lung cancer research
  • Ava Kwong
    Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
    Research Interests: Molecular diagnostics for breast cancer, Lung cancer, pancreatic & prostate cancers, hematological malignancy, colon cancer, neurological and Genetic Disorders, cancer stem cells & therapies, early detection markers for breast, lung cancer, molecular targeted therapies of cancer
  • Xuefen Le Bourhis
    INSERM U908 “Cell Plasticity and Cancer”, University of Lille, Villeneuve d’Ascq, France.
    Research Interests: Molecular mechanisms of cancer cell plasticity, Breast cancer cells plasticity and metastasis, epigenetics and resistance to treatments for pediatric gliomas, inference, interrogation and engineering of regulatory networksn
  • Gary Li
    Executive Director, Oncology Ignyta, Inc. San Diego, CA, USA.
    Research Interests: Kinase inhibitor, gastric cancer, autophagy, drug combination
  • Ji-Liang Li
    Faculty of Medicine and Dentistry, University of Plymouth, Plymouth, UK.
    Research Interests: Tumour microenvironment and translational cancer medicine, the combination of cancer target therapy and immunotherapy, tumour associated macrophages, Notch signaling in cancer biology, tumour resistance to target therapy and immunotherapy, hypoxia and angiogenesis pathways in cancer biology, microRNAs in cancer target therapy and immunotherapy, experimental mouse tumour models
  • Shuen-Kuei Liao
    The PhD Program for Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan, China.
    Research Interests: Stem cell biology, nanotechnology and tissue engineering
  • Thomas Liehr
    Jena University Hospital, Institute of Human Genetics, Friedrich Schiller University, Jena, Germany.
    Research Interests: Inherited and acquired marker and derivative chromosomes, karyotype evolution, uniparental disomy, interphase architecture, probe set-developments
  • Silvana Morello
    Department of Pharmaceutical and Biomedical Sciences, University of Salerno, Via Ponte Don Melillo, Fisciano, Salerno, Italy.
    Research Interests: Tumor microenvironment, metastatic melanoma, prognostic factor, tumor immunology, mitochondrial metabolism of tumor cells
  • Reinhold Munker
    Department of Medicine, Section of Hematology and Oncology, Louisiana State University, Health Sciences Center, Shreveport, LA, USA.
    Research Interests: Proliferation of leukemic cells, microRNAs, autoantibodies, cancer, rare types of leukemia, benign and malignant blood disorders, stem cell transplantation, immunotherapy
  • Alberto Giuseppe Passi
    Department of Medicine and and Surgery (DMC), University of Insubria, Varese, Italy.
    Research Interests: Cancer biology, cell migration, collagen, glycosaminoglycans
  • DR. PRAVIN POTDAR
    Department of Molecular Medicine & Biology, Jaslok Hospital & Research Centre, Mumbai, India.
  • Luis Raez
    Memorial Cancer Institute, Memorial Healthcare System/Florida International University (FIU) Miami, FL, USA.
    Research Interests: Lung cancer, head and neck cancers, chemotherapeutic agents and combinations, cancer vaccines
  • Michele Reni
    Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Research Interests: Management of pancreatic adenocarcinoma, gastro-esophageal cancers, central nervous system tumors
  • Boris Reva
    Department of Genetics and Genomic Sciences, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
    Research Interests: Cancer genomics, molecular evolution, bioinformatics, protein folding
  • Palma Rocchi
    Centre National de la Recherche Scientifique, Unités Mixtes de Recherche 7258, Centre de Recherche en Cancérologie de Marseille, Marseille, France.
    Research Interests: Hsp27, castration resistant prostate cancer, translationaly controlled tumor protein, novel therapeutic target, nanoparticles technology, prostate cancer therapy
  • Luis Rodrigo
    Gastroenterology Unit, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.
    Research Interests: Gastroenterology, hepatology, celiac disease, autoimmune-associated diseases
  • Ahmad R. Safa
    Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.
    Research Interests: Molecular and biochemical mechanisms of intrinsic and acquired resistance to chemotherapeutic drugs, apoptosis (cell death) in cancer cells, cancer stem cells, drug discovery and development, cancer treatment
  • Lúcio Lara Santos
    Department of Surgical Oncology, Portuguese Oncology Institute-Porto (IPO-Porto), Rua Dr. António Bernardino de Almeida, Porto, Portugal.
    Research Interests: Surgical oncology and carcinogenesis, experimental pathology and oncology, gastrointestinal, breast cancer, cancers related to infections
  • Hildegard M. Schuller
    Experimental Oncology Laboratory, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA.
    Research Interests: Comparative pathology, lung cancer, G protein-coupled receptors, pancreatic cancer, stem cell
  • Rafat A. Siddiqui
    Nutrition Science and Food Chemistry, Agriculture Research Station, Virginia State University, Petersburg, VA, USA.
    Research Interests: Dietary fats, molecular nutrition, cancer, fatty acids-polyphenol conjugates
  • Seema Singh
    Department of Pathology, College of Medicine, Mitchell Cancer Institute, University of South Alabama, 1660 Springhill Avenue, Mobile, AL, USA.
    Research Interests: Role of inflammatory signaling in cancer progression, angiogenesis and metastasis, cancer stem cells and cancer health disparities
  • Ira-Ida Skvortsova
    Department of Therapeutic Radiology and Oncology, University of Innsbruck, Innsbruck, Austria.
    Research Interests: Cancer stem cells, therapy resistance, metastasis development, cancer cell metabolism
  • Giovanni Tuccari
    Department of Human Pathology "Gaetano Barresi," University of Messina, Messina, Italy.
    Research Interests: Triple negative breast carcinomas, prognostic markers, HER2 heterogeneity, human pathology
  • Tamara Lah Turnšek
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.
    Research Interests: Biology of tumours, stem cells in relation to glioblastoma progression, mesenchymal stem cells as part of tumour micro-environment and as therapeutic agents in regenerative medicine and oncology
  • Yogesh Vashist
    Department of Surgery, Asklepios Harzklinik Goslar, Goslar, Germany.
  • Paula Videira
    Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.
    Research Interests: Cancer-associated glycans, dendritic cell-based vaccines, novel biomarkers in cancer
  • Israel Vlodavsky
    Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
    Research Interests: Cancer metastasis, heparanase, extracellular matrix, tumor microenvironment in cancer progression
  • Yaoqi Alan Wang
    Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Research Interests: Cancer biology, glioblastoma, neoplasms, tumors, chemical compounds, glioma, stem cells, pancreatic neoplasms, prostatic neoplasms, adenocarcinoma
  • Zhou Wang
    Shadyside Medical Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Guofeng Xie
    Department of Medicine, Division of Gastroenterology & Hepatology and Program in Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
    Research Interests: Esophageal motility disorders, GERD, colon cancer
  • Ren Xu
    Department of Molecular and Biomedical Pharmacology, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
    Research Interests: Microenvironmental signals, breast cancer progression, breast cancer metastasis, ECM microenvironment
  • Vladimir Zaichick
    Medical Radiological Research Center, Obninsk, Russia.
    Research Interests: In vivo and in vitro nuclear analytical methods of chemical element contents measurement in tissues and fluids of human body, age- and gender-dependence of chemical element contents in tissues and fluids, levels of chemical element contents in tissues and fluids as tumour’s markers
  • Fenghuang Zhan
    Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, USA..
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties